Remo H.M. Furtado
General / Preventive / Lipids
Clinical Research Institute
About
Remo H.M. Furtado works in General / Preventive / Lipids affiliated with Clinical Research Institute.
Remo H.M. Furtado is a cardiologist and clinical researcher serving as Chief Scientific Officer at the Brazilian Clinical Research Institute (BCRI) in São Paulo, Brazil, with affiliations including Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo and past postdoctoral research at Brigham and Women's Hospital / TIMI Study Group, Harvard University. He has authored or co-authored publications on SGLT2 inhibitors, antiplatelet therapy, evolocumab in post-PCI patients, and COVID-19 anticoagulation and hydroxychloroquine trials.
Research focus
Acute Coronary SyndromesPercutaneous Coronary Intervention outcomesAntiplatelet TherapySGLT2 inhibitors and GLP-1 agonists in type 2 diabetes cardiovascular preventionCOVID-19 clinical trials in cardiovascular disease
Impact
70 pubs · 7,637 cites · h-index 21
Affiliations
Work Experience
Chief Scientific Officer
BCRI - Brazilian Clinical Research Institute
Postdoctoral Research Fellow / Clinical Trialist
Brigham and Women's Hospital, Harvard University / TIMI Study Group
Médico Assistente - Unidade Coronária
Hospital Israelita Albert Einstein